1
|
False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer.
|
Am J Nucl Med Mol Imaging
|
2012
|
1.42
|
2
|
Incidental pituitary uptake on whole-body 18F-FDG PET/CT: a multicentre study.
|
Eur J Nucl Med Mol Imaging
|
2010
|
1.35
|
3
|
The usefulness of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with Langerhans cell histiocytosis.
|
Ann Nucl Med
|
2012
|
1.13
|
4
|
Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.
|
Thyroid
|
2013
|
1.08
|
5
|
Pulmonary amyloidosis mimicking multiple metastatic lesions on F-18 FDG PET/CT.
|
Lung Cancer
|
2010
|
1.07
|
6
|
18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer.
|
J Nucl Med
|
2012
|
1.02
|
7
|
Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on ¹⁸F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma.
|
Eur J Nucl Med Mol Imaging
|
2013
|
0.96
|
8
|
Usefulness of SPECT/CT for equivocal findings on (131)I whole-body scan in a patient with differentiated papillary thyroid cancer.
|
Clin Nucl Med
|
2014
|
0.90
|
9
|
Combined Cerenkov luminescence and nuclear imaging of radioiodine in the thyroid gland and thyroid cancer cells expressing sodium iodide symporter: initial feasibility study.
|
Endocr J
|
2011
|
0.90
|
10
|
Dose-dependent frontal hypometabolism on FDG-PET in methamphetamine abusers.
|
J Psychiatr Res
|
2009
|
0.89
|
11
|
Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using (18)F-FDG PET/CT.
|
Clin Endocrinol (Oxf)
|
2009
|
0.89
|
12
|
Bone scintigraphic findings of hypophosphatemic osteomalacia associated with adefovir therapy: involvement of lower extremity skeletons.
|
Clin Nucl Med
|
2013
|
0.85
|
13
|
Enhanced antitumor effects by combination gene therapy using MDR1 gene shRNA and HSV1-tk in a xenograft mouse model.
|
Cancer Lett
|
2009
|
0.85
|
14
|
Isolated facial muscle metastasis from renal cell carcinoma on F-18 FDG PET/CT.
|
Clin Nucl Med
|
2010
|
0.84
|
15
|
Prognostic implications of microscopic involvement of surgical resection margin in patients with differentiated papillary thyroid cancer after high-dose radioactive iodine ablation.
|
Ann Nucl Med
|
2012
|
0.83
|
16
|
Characterization of partial ligation-induced carotid atherosclerosis model using dual-modality molecular imaging in ApoE knock-out mice.
|
PLoS One
|
2013
|
0.83
|
17
|
Peritoneal carcinomatosis in patients with ovarian cancer: enhanced CT versus 18F-FDG PET/CT.
|
Clin Nucl Med
|
2013
|
0.82
|
18
|
Extra-thoracic tumor burden but not thoracic tumor burden on (18)F-FDG PET/CT is an independent prognostic biomarker for extensive-disease small cell lung cancer.
|
Lung Cancer
|
2013
|
0.82
|
19
|
Dual reporter gene imaging for tracking macrophage migration using the human sodium iodide symporter and an enhanced firefly luciferase in a murine inflammation model.
|
Mol Imaging Biol
|
2013
|
0.82
|
20
|
Targeting of hepatocellular carcinoma with glypican-3-targeting peptide ligand.
|
J Pept Sci
|
2011
|
0.81
|
21
|
F-18 fluorodeoxyglucose PET/CT and post hoc PET/MRI in a case of primary meningeal melanomatosis.
|
Korean J Radiol
|
2013
|
0.80
|
22
|
Prognostic Significance of Intratumoral Metabolic Heterogeneity on 18F-FDG PET/CT in Pathological N0 Non-Small Cell Lung Cancer.
|
Clin Nucl Med
|
2015
|
0.79
|
23
|
A novel estrogen receptor intramolecular folding-based titratable transgene expression system.
|
Mol Ther
|
2009
|
0.79
|
24
|
Superiority of delayed risk stratification in differentiated thyroid cancer after total thyroidectomy and radioactive iodine ablation.
|
Nucl Med Commun
|
2014
|
0.79
|
25
|
Rituximab-induced pneumonitis on F-18 FDG PET/CT in patient with non-Hodgkin lymphoma.
|
Clin Nucl Med
|
2010
|
0.79
|
26
|
Radioiodine SPET/CT guided needle aspiration as a useful technique for recurrence surveillance in a thyroidectomized differentiated thyroid cancer patient with negative US and serum Tg and positive Tg of the lymph node aspirate.
|
Hell J Nucl Med
|
2013
|
0.79
|
27
|
Evaluation of the reversal of multidrug resistance by MDR1 ribonucleic acid interference in a human colon cancer model using a Renilla luciferase reporter gene and coelenterazine.
|
Mol Imaging
|
2010
|
0.79
|
28
|
Combined RNA interference of hexokinase II and (131)I-sodium iodide symporter gene therapy for anaplastic thyroid carcinoma.
|
J Nucl Med
|
2011
|
0.79
|
29
|
Intratumoral versus intravenous gene therapy using a transcriptionally targeted viral vector in an orthotopic hepatocellular carcinoma rat model.
|
J Vasc Interv Radiol
|
2012
|
0.79
|
30
|
Enhanced scintigraphic visualization of thyroglossal duct remnant during hypothyroidism after total thyroidectomy: prevalence and clinical implication in patients with differentiated thyroid cancer.
|
Thyroid
|
2007
|
0.79
|
31
|
Enhancement of natural killer cell cytotoxicity by sodium/iodide symporter gene-mediated radioiodine pretreatment in breast cancer cells.
|
PLoS One
|
2013
|
0.79
|
32
|
Metabolic parameters using ¹⁸F-FDG PET/CT correlate with occult lymph node metastasis in squamous cell lung carcinoma.
|
Eur J Nucl Med Mol Imaging
|
2014
|
0.79
|
33
|
Incidental detection of increased (18)F-FDG uptake and its follow-up in patients with granulomatous prostatitis after BCG treatment for urinary bladder cancer.
|
Hell J Nucl Med
|
2014
|
0.79
|
34
|
Noninvasive imaging of apoptosis induced by adenovirus-mediated cancer gene therapy using a caspase-3 biosensor in living subjects.
|
Mol Imaging
|
2014
|
0.79
|
35
|
In vivo monitoring of survival and proliferation of hair stem cells in a hair follicle generation animal model.
|
Mol Imaging
|
2013
|
0.78
|
36
|
Prediction for recurrence using F-18 FDG PET/CT in pathologic N0 lung adenocarcinoma after curative surgery.
|
Ann Surg Oncol
|
2013
|
0.78
|
37
|
Effect of parotid gland massage on parotid gland Tc-99m pertechnetate uptake.
|
Thyroid
|
2012
|
0.78
|
38
|
18F-FDG PET/CT finding of bilateral primary breast mucosa-associated lymphoid tissue lymphoma.
|
Clin Nucl Med
|
2015
|
0.78
|
39
|
Combined radionuclide-chemotherapy and in vivo imaging of hepatocellular carcinoma cells after transfection of a triple-gene construct, NIS, HSV1-sr39tk, and EGFP.
|
Cancer Lett
|
2009
|
0.78
|
40
|
Human sodium iodide symporter added to multidrug resistance 1 small hairpin RNA in a single gene construct enhances the therapeutic effects of radioiodine in a nude mouse model of multidrug resistant colon cancer.
|
Cancer Biother Radiopharm
|
2010
|
0.77
|
41
|
In vitro antiproliferative characteristics of flavonoids and diazepam on SNU-C4 colorectal adenocarcinoma cells.
|
J Nat Med
|
2008
|
0.77
|
42
|
Emptying effect of massage on parotid gland radioiodine content.
|
Nucl Med Commun
|
2014
|
0.77
|
43
|
Recurrence of a functional adrenocortical oncocytoma of borderline malignant potential showing high FDG uptake on 18F-FDG PET/CT.
|
Ann Nucl Med
|
2013
|
0.77
|
44
|
Combined E7-dendritic cell-based immunotherapy and human sodium/iodide symporter radioiodine gene therapy with monitoring of antitumor effects by bioluminescent imaging in a mouse model of uterine cervical cancer.
|
Cancer Biother Radiopharm
|
2011
|
0.76
|
45
|
Quantification of Intratumoral Metabolic Macroheterogeneity on 18F-FDG PET/CT and Its Prognostic Significance in Pathologic N0 Squamous Cell Lung Carcinoma.
|
Clin Nucl Med
|
2016
|
0.76
|
46
|
Evaluation of kidney repair capacity using 99mTc-DMSA in ischemia/reperfusion injury models.
|
Biochem Biophys Res Commun
|
2011
|
0.76
|
47
|
Clinical applications of SPECT/CT after first I-131 ablation in patients with differentiated thyroid cancer.
|
Clin Endocrinol (Oxf)
|
2014
|
0.76
|
48
|
Macroaggregated albumin (MAA) injected in hepatic artery visualized in a recanalized paraumbilical vein.
|
Clin Nucl Med
|
2012
|
0.75
|
49
|
Enhanced antiproliferative effects of combination hexokinase II shRNA and NIS gene therapy on vascular smooth muscle cells.
|
Nucl Med Biol
|
2011
|
0.75
|
50
|
Estimation of external radiation dose to caregivers of patients treated with radioiodine after thyroidectomy.
|
Health Phys
|
2014
|
0.75
|
51
|
Paradoxical exacerbation of preexisting Graves' disease induced by insufficient radioiodine treatment: a report of five patients.
|
Nucl Med Commun
|
2009
|
0.75
|
52
|
Clinical outcomes of low-dose and high-dose postoperative radioiodine therapy in patients with intermediate-risk differentiated thyroid cancer.
|
Nucl Med Commun
|
2016
|
0.75
|
53
|
Engineering of Radioiodine-Labeled Gold Core-Shell Nanoparticles As Efficient Nuclear Medicine Imaging Agents for Trafficking of Dendritic Cells.
|
ACS Appl Mater Interfaces
|
2017
|
0.75
|
54
|
Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma.
|
Eur J Nucl Med Mol Imaging
|
2002
|
0.75
|
55
|
Measurements and prediction of the ambient dose rate from patient receiving radioiodine administration after thyroid ablation.
|
Radiat Prot Dosimetry
|
2011
|
0.75
|
56
|
Combined RNA interference of adenine nucleotide translocase-2 and ganciclovir therapy in hepatocellular carcinoma.
|
Nucl Med Biol
|
2013
|
0.75
|
57
|
Corrigendum: Tracking of dendritic cell migration into lymph nodes using molecular imaging with sodium iodide symporter and enhanced firefly luciferase genes.
|
Sci Rep
|
2015
|
0.75
|
58
|
Direct comparison of adenosine and adenosine 5'-triphosphate as pharmacologic stress agents in conjunction with Tl-201 SPECT: Hemodynamic response, myocardial tracer uptake, and size of perfusion defects in the same subjects.
|
J Nucl Cardiol
|
2006
|
0.75
|
59
|
Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
|
Clin Nucl Med
|
2016
|
0.75
|
60
|
High and low radioiodine doses to indicate a simple renal cyst.
|
Hell J Nucl Med
|
2012
|
0.75
|
61
|
Prognostic Value of Metabolic Parameters of 18F-FDG PET/CT and Apparent Diffusion Coefficient of MRI in Hepatocellular Carcinoma.
|
Clin Nucl Med
|
2016
|
0.75
|
62
|
Solitary splenic metastasis from hepatocellular carcinoma detected on (18)F-FDG PET/CT.
|
Clin Nucl Med
|
2015
|
0.75
|
63
|
Evaluation of hepatic function with (99m)Tc-galactosylated serum albumin scintigraphy in patients with malaria: comparison with (99m)Tc-colloid scintigraphy and liver ultrasonography.
|
Nucl Med Commun
|
2007
|
0.75
|
64
|
Synthesis and evaluation of a radioiodinated bladder cancer specific peptide.
|
Bioorg Med Chem
|
2012
|
0.75
|